Ascend Vitality Expands National Telehealth Network to Provide Physician-Directed Access to Compounded Peptide Therapies

Ascend Vitality Expands National Telehealth Network to Provide Physician-Directed Access to Compounded Peptide Therapies GlobeNewswire November 17, 2025 Sheridan, WY, Nov. 17, 2025 (GLOBE NEWSWIRE) — Ascend Vitality announced today that it has expanded its fully licensed telehealth operations across all 50 states, reinforcing its position as a provider of physician-directed access to compounded peptide […]

ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use

(Brussels:ONWD),(Euronext Amsterdam:ONWD),(OTC US:ONWRY),(Other OTC:ONWRY), THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) US FDA clearance now allows use of the ARC-EX(R) System both in clinics and homes ARC-EX is the first and only FDA-cleared technology demonstrated to improve hand strength and sensation in people

Technip Energies to supply liquefied CO2 marine loading arms for phase 2 of the Northern Lights project in Norway

(Paris:TE),(Euronext Amsterdam:TE), Technip Energies (PARIS:TE) Loading Systems has been awarded a contract to supply three fully electric marine loading arms for phase 2 of the Northern Lights CO2 transport and storage project in Øygarden, Norway. The loading solution will be installed at the new Northern Lights jetty and will consist of three marine loading arms

Technip Energies to supply liquefied CO2 marine loading arms for phase 2 of the Northern Lights project in Norway

Technip Energies to supply liquefied CO2 marine loading arms for phase 2 of the Northern Lights project in Norway GlobeNewswire November 17, 2025 Technip Energies (PARIS:TE) Loading Systems has been awarded a contract to supply three fully electric marine loading arms for phase 2 of the Northern Lights CO2 transport and storage project in Øygarden,

ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use

ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use GlobeNewswire November 17, 2025 THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) US FDA clearance now allows use of the ARC-EX(R) System both in clinics and homes ARC-EX is the first

From InnQuest to roommaster – A New Era of Unified, AI-Driven Hospitality Technology Begins

A familiar name in hospitality technology is stepping into clearer focus. roommaster, previously known as InnQuest, today unveils its company rebrand alongside the integration of AI-based Revenue Management Software and an AI Call Agent, marking a strategic evolution from trusted legacy system to modern, unified platform for independent hoteliers. The rebrand aligns what hoteliers already

JLL Receives Frost & Sullivan’s 2025 APAC and Singapore Company of the Year Recognitions for Facility Management

JLL is recognized for redefining facility management through AI-driven innovation, people-centric design, and sustainability leadership across Asia-Pacific and Singapore. Frost & Sullivanis pleased to announce that JLLhas received the 2025 Asia-Pacific and Singapore Company of the Year Recognitions in the facility management (FM) industry for its exceptional performance, innovation, and customer-centric excellence. These honors underscore

JLL Receives Frost & Sullivan’s 2025 APAC and Singapore Company of the Year Recognitions for Facility Management

JLL is recognized for redefining facility management through AI-driven innovation, people-centric design, and sustainability leadership across Asia-Pacific and Singapore. Frost & Sullivanis pleased to announce that JLLhas received the 2025 Asia-Pacific and Singapore Company of the Year Recognitions in the facility management (FM) industry for its exceptional performance, innovation, and customer-centric excellence. These honors underscore

VEON Commences USD 100 million Buyback Program

(NasdaqGM:VEON), Dubai, November 17, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or the “Company”), announces that it has commenced the buyback program (the “Program”) announced on November 10, 2025. The Program authorized by VEON's Board enables the Company to buy back ADSs and/or outstanding bonds in an amount up to USD 100

Agomab Announces Positive Topline Phase 2a Data for Ontunisertib in Fibrostenosing Crohn’s Disease

— STENOVA trial achieves primary endpoint in 103 study participants after 12 weeks of treatment — — Pharmacokinetic results confirm gut-restricted profile of ontunisertib in FSCD patients — — Positive efficacy signals observed for several exploratory clinical endpoints — — Ongoing open-label extension study supports longer-term safety and tolerability profile observed to date — Antwerp,

Scroll to Top